I don’t! I mean I used to lol I used to live there and honestly everything from the crime, to the creeps (been sexually assaulted) to the racism (including anti-black attitudes from other black people) to the filth turned me off.. Aka when it moved 300 miles to go to college, even though I was accepted to all my choices lol. I still dislike to go back (drama, rude ppl etc) but I don’t mind nearly as I used to
"Most of the US effort, which will draw heavily on its military medical corps..."
A strong military presence was stressed in the press release and every article I’ve read… Given the US’ track record and the amount of resources in West Africa (esp my country, which was also affected) I am not happy and I am still suspicious.
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
The new antibody targets ROR1, a protein used by embryonic cells during early development and exploited by cancer cells to promote tumor growth and metastasis, the latter responsible for 90 percent of all cancer-related deaths.
Because ROR1 is not expressed by normal adult cells, scientists believe it is a biomarker of cancer cells in general and cancer stem cells in particular. Because it appears to drive tumor growth and disease spread, they believe it also presents an excellent target for anti-cancer therapy.
Developed at UC San Diego Moores Cancer Center by Thomas Kipps, MD, PhD, who holds the Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues, the antibody is called cirmtuzumab (also known as UC-961). In previous animal studies, Kipps’ team reported that ROR1 is singularly expressed on CLL and also on a variety of different cancers, including cancers of the breast, pancreas, colon, lung and ovary. In mouse models of CLL, ROR1 acts as an accelerant when combined with another oncogene to produce a faster-growing, more aggressive cancer.
Cirmtuzumab was developed under the auspices of the California Institute for Regenerative Medicine’s HALT leukemia grant awarded to Dennis Carson, MD, principal investigator, and Catriona Jamieson, MD, PhD, co-principal investigator to develop six distinct therapies against cancer stem cells. Kipps led one of the six projects and generated antibodies against ROR1, leading to the cirmtuzumab trial in patients with CLL.
“The primary goal of this phase I clinical trial is to evaluate whether cirmtuzumab is a safe and well-tolerated cancer stem cell-targeted agent in patients with CLL,” said Jamieson, chief of the Division of Regenerative Medicine, associate professor of medicine, director of stem cell research at UC San Diego Moores Cancer Center, deputy director of the Sanford Stem Cell Clinical Center and a principal investigator of the cirmtuzumab clinical trial.
Michael Choi, MD, assistant clinical professor of medicine and co-principal investigator of the clinical trial said, “The trial will involve patients with relapsed or refractory CLL, who will receive an intravenous infusion every 14 days at Moores, followed by regular monitoring and clinic visits to assess efficacy and identify and manage any adverse effects. Initial treatment is planned for two months.”
To learn more about eligibility for this clinical trial, call Reilly L. Kidwell at 858-534-4801 or Samuel Zhang at 858-534-8127.
US President Barack Obama will try to “turn the tide” on the Ebola epidemic Tuesday by ordering 3,000 US military personnel to west Africa to curtail its spread as China also dispatched more experts to the region.
The White House said Obama will travel to the Centers for Disease Control and Prevention in Atlanta — where US Ebola victims were treated — to make the announcement, meant to spur a global effort to tackle the outbreak that has already killed 2,400 people.
It comes as alarm grows that the worst-ever Ebola epidemic which spread through Liberia, Sierra Leone and Guinea before reaching Nigeria, is out of control. A separate strain of the disease has appeared in the Democratic Republic of Congo.
Most of the US effort, which will draw heavily on its military medical corps, will be concentrated in impoverished Liberia — the worst hit nation — with plans to build 17 Ebola treatment centres with 100 beds in each.
China is also sending more medics to neighbouring Sierra Leone to help boost laboratory testing for the virus, raising the total number of Chinese medical experts there to 174, the UN said Tuesday.
Because we need troops and not doctors and medicine, keeps your tentacles to yourself US and Obama
It’s linked on my page but you can also follow this link. I will post different things on there than I do here so that people don’t get tired of seeing the same thing if they are subscribed to both and this account will completely lack my annoying personal posts. It is not my personal twitter…